Mary Bakhanashvili - Infectious Diseases

Author Information

Mary Bakhanashvili is a researcher affiliated with the Infectious Diseases Unit at Sheba Medical Center, located in Tel-Hashomer, Israel. Her work primarily explores the roles of proteins like p53 in cellular processes, with a particular focus on their involvement in the context of infectious diseases and DNA synthesis.

Research Contributions

Mary Bakhanashvili has made significant contributions to the understanding of the p53 protein's role in various cellular mechanisms. Her research includes studying p53's involvement in mitochondrial RNA degradation, regulation of its own expression, and the correction of errors during DNA synthesis, particularly in the context of HIV-1 infection. Her work spans the investigation of p53's exoribonuclease activities and its impact on telomerase regulation in both malignant and non-malignant cells, highlighting its multifaceted role in cellular regulation and stress response.

Aliases

Mary Bakhanashvili is also known by other names in academic publications, including M Bakhanashvili.

Publication and Citation Metrics

Metric	Value
Total Papers	54
Total Citations	1210
H-index	22
Affiliation	Infectious Diseases Unit, Sheba Medical Center, 5265601, Tel-Hashomer, Israel.

Publications:

Mitochondrial matrix-localized p53 participates in degradation of mitochondrial RNAs.

DOI: 10.1016/j.mito.2021.03.007

Year: 2021

p53 regulates its own expression by an intrinsic exoribonuclease activity through AU-rich elements

DOI: 10.1007/s00109-020-01884-0

Year: 2020

Diagnosis of HIV-1 infection: Performance of Xpert Qual and Geenius supplemental assays in fourth generation ELISA-reactive samples.

DOI: 10.1016/j.jcv.2018.01.007

Year: 2018

Cytoplasmic p53 contributes to the removal of uracils misincorporated by HIV-1 reverse transcriptase.

DOI: 10.1016/j.bbrc.2018.02.159

Year: 2018

Removal of ribonucleotides by p53 protein incorporated during DNA synthesis by HIV-1 reverse transcriptase

DOI: 10.1097/QAD.0000000000001339

Year: 2017

p53 in the mitochondria, as a trans-acting protein, provides error-correction activities during the incorporation of non-canonical dUTP into DNA

DOI: 10.18632/oncotarget.12331

Year: 2016

The effects of erythropoietin signaling on telomerase regulation in non-erythroid malignant and non-malignant cells.

DOI: 10.1016/j.bbrc.2014.05.105

Year: 2014

Abstract 4110: Downregulation of telomerase activity in response to epoxomicin in MM cells.

DOI: 10.1158/1538-7445.AM2013-4110

Year: 2013

The Role of P53 Exonuclease in Accuracy of DNA Synthesis and Sensitivity to Nucleoside Analogs in Various Compartments of Cells

DOI: 10.5772/54220

Year: 2013

Ribonuclease activity of p53 in cytoplasm in response to various stress signals

DOI: 10.4161/cc.19812

Year: 2012

What is the Prognosis for Individuals with HSV?

What are Future Directions in Protein Targeting?

How do ACTs Work?

How Can We Prevent Infections?

Is There a Vaccine for E. Coli?

What is the treatment?

What Tests are Performed on Stool Samples?

What Role Did the NIH Play During the COVID-19 Pandemic?

What are the benefits of using Dexamethasone in COVID-19?

What is Herpes?

Partnered Content Networks

Relevant Topics